Summary
In a pharmacokinetic study of the new analgesic and anti-inflammatory drug indoprofen, plasma levels and urinary excretion were determined in four healthy volunteers after 100 mg and 200 mg iv, and after 100 mg (capsules) and 200 mg (tablets) oral doses. After iv administration, the mean biological half-life (t1/2 β) was about 2 h (range 1.4 to 3.2 h). The apparent volume of distribution Vdβ ranged between 11 to 17 % of body weight, indicating its limited extravascular distribution. Most of the drug was excreted in urine as glucuronide and a smaller proportion as unchanged indoprofen: the 24 h urinary excretion of these compounds accounted for 67 to 95 % of an iv dose. Peak plasma levels occurred between 30 and 120 minutes after oral administration of 100 mg as capsules or 200 mg as tablets. The mean biological half-life was about 2 h, as after iv administration. The bioavailability of oral doses was assessed using both plasma levels and urinary excretion data. The absorption of capsules and tablets was practically complete, that of the former being faster.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Buttinoni, A., Cuttica, A., Franceschini, J., Mandelli, V., Orsini, G., Passerini, N., Turba, C., Tommasini, R.: Pharmacological study on a new analgesic anti-inflammatory drug: α-[4-(1-oxo-2-iso-indolinyl)-phenyl]-propionic acid or K 4277. Arzneimittel-Forsch.23, 1100–1107 (1973)
Fuccella, L.M., Conti, F., Corvi, G., Mandelli, V., Randelli, M., Stefanelli, G.: Double-blind study of the analgesic effect of indoprofen (K 4277). Clin. Pharmacol. Ther.17, 277–283 (1975)
Pedronetto, S., Gorini, F., Mandelli, V., Fuccella, L.M.: Double-blind trial of the new analgesic and anti-inflammatory drug indoprofen in post-episiotomic pain. J. int. Med. Res.3, 16–20 (1975)
Ventafridda, V., Martino, G., Mandelli, V., Emanueli, A.: Indoprofen, a new analgesic and anti-inflammatory drug in cancer pain. Clin. Pharmacol. Ther.17, 284–289 (1975)
Fuccella, L.M., Goldaniga, G.C., Moro, E., Tamassia, V., Tosolini, G.P., Valzelli, G.: Fate of the analgesic and anti-inflammatory drug K 4277 after oral administration to man. Europ. J. clin. Pharmacol.6, 256–260 (1973)
Tosolini, G.P., Forgione, A., Moro, E., Mandelli, V.: Determination of plasma and urinary levels of an analgesic anti-inflammatory α-[4-(2-isoindolinyl)-phenyl]-propionic acid derivative by gas-liquid chromatography. J. Chromatogr.92, 61–68 (1974)
Riegelmann, S., Loo, J.C.K., Rowland, M.: Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment. J. pharm. Sci.57, 117–123 (1968)
Portmann, G.A.: Pharmacokinetics. In: Current concepts in the pharmaceutical sciences: Biopharmaceutics, (ed. J. Swarbrick), p. 304. Philadelphia: Lea & Febiger (1970)
Loo, J.C.K.: Pharmacokinetic methods of assessing drug absorption: Evaluation and the application of kinetic methods in the investigation of bioavailability of solid oral dosage forms. Thesis, pp. 17–18. San Francisco: University of California 1971
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tamassia, V., Corvi, G., Moro, E. et al. Pharmacokinetics and bioavailability of indoprofen in man. Eur J Clin Pharmacol 10, 257–262 (1976). https://doi.org/10.1007/BF00558338
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00558338